Photographs by Maciek Miloch, Set Design by Zuza Slominska, Food Styling by Nadine Page, Prop Styling by Pawel Wyszynski.

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has approved Susvimo® (ranibizumab injection) 100 mg/mL for the treatment of diabetic macular edema ...

Yale researchers have created "Ochre," a genomically recoded organism that enables the production of synthetic proteins with ...

Synthetic biologists from Yale were able to re-write the genetic code of an organism - a novel genomically recoded organism (GRO) with one stop codon - using a cellular platform that they developed ...

Researchers have revealed novel sequence-structure-property relationships for customizing engineered living materials (ELMs), enabling more precise control over their structure and how they respond to ...

Meanwhile, work continues to scale up the production of tadpoles from a few thousand now to the tens of thousands. But it is not only the toad that is ripe for genetic engineering. A team at the ...

"The main difference between their work and ours," Hayashi said of the ... said it represents "a notable accomplishment in mammalian genetic engineering." He said the technique used in this ...

Resistance to diseases could be introduced into susceptible crops using genetic engineering. Not only can this protect the crop, it can also safeguard farmers' livelihoods. An example is ...

Rice University researchers have revealed novel sequence-structure-property relationships for customizing engineered living ...

Genetic engineering is a scientific process that involves altering the DNA of organisms to produce desired traits. This technology has rapidly advanced since the discovery of DNA’s structure in 1953, ...

The Noonan lab at Yale University is focused on understanding how HARs contribute to the evolution of uniquely human brain features.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...